[1]
N. K. Fakree and S. H. Ali, “Effect of COX-2 Inhibitors Selectivity on Lipid Profile in Hyperlipidemic and Normolipidemic Type 2 Diabetics”, Iraqi Journal of Pharmaceutical Sciences , vol. 18, no. Suppl., pp. 7–13, Mar. 2017, doi: 10.31351/vol18issSuppl.pp7-13.